Breastfeeding during tacrolimus therapy

Obstetrics and Gynecology

Volumn 107, Issue 2 II, 2006, Pages 453-455

  Gardiner, Sharon J ^a   Begg, Evan J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; AZATHIOPRINE; DILTIAZEM; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; BREAST FEEDING; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG MILK LEVEL; DRUG SAFETY; HUMAN; INFANT; KIDNEY TRANSPLANTATION; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; BLOOD; BREAST MILK; CHEMISTRY; FEMALE;

ADULT; BREAST FEEDING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY TRANSPLANTATION; MILK, HUMAN; TACROLIMUS;

EID: 33645460873     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aog.0000164052.66219.c7     Document Type: Article

References (7)

1. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000;343:118-26.
2. Bennett PN, editor. Drugs and human lactation: a comprehensive guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals, and environmental and occupational chemicals in human milk. 2nd ed. Amsterdam: Elsevier, 1996.
3. National Center for Health Statistics, Clinical growth charts. Available at www.cdc.gov/nchs/data/nhanes/growthcharts/set1clinical/Cj41c017.pdf. Retrieved January 17, 2005.
4. Keevil BG, McCann SJ, Cooper DP, Morris MR. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 2002;39:487-92.
5. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004;43:623-53.
6. Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997;64:559-65.
7. French AE, Soldin SJ, Soldin OP, Koren G. Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother 2003;37:815-8.